Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Back to alerts
MANGALAMNSEMangalam Drugs And Organics Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 15 Oct, 2025 · 15:40 IST

NCLT admits merger petition; final hearing set for December 16, 2025

Regulatory & Legal View source PDFExplain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.0%Reaction day
₹69.00
prior close
₹69.11
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+1.4% vs market
Pharmaceuticals peers, median of 152sector+0.2%+1.7% vs sector

On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 1.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.2
10m
+1.2
15m
+0.8
30m
+0.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.0+0.5+1.4+0.2+1.7
Next day
+2.0+0.0+2.0-0.2+2.2
2d
+0.7+1.0-0.3+0.1+0.6
3d
+2.5+2.1+0.4+0.8+1.7
4d
+2.2+1.6+0.6+0.5+1.7
5d
-1.4+1.2-2.7+0.0-1.4
1w
-6.5+1.9-8.4-0.0-6.4
15d
-11.6+0.4-12.0-1.5-10.1
1m
-11.6+1.5-13.1-0.1-11.5
2m
-63.8-4.4-59.3-4.7-59.0
3m
-31.9-7.2-24.7-8.7-23.2
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 152Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The NCLT Mumbai Bench admitted the petition on September 23, 2025 seeking approval to merge Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited into Mangalam Drugs and Organics Limited. Authorities must be served with notice and may respond within 30 days. The case is listed for final hearing on December 16, 2025, so the merger has not yet received final approval.

Likely market impact

The merger has cleared an early regulatory step, but final approval is pending. Shareholder benefits, risks and possible stock-price impact remain uncertain.